Hjorthøj C - Search Results

1

Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark.

Hjorthøj C, Posselt CM, Nordentoft M. Hjorthøj C, et al. JAMA Psychiatry. 2021 Sep 1;78(9):1013-1019. doi: 10.1001/jamapsychiatry.2021.1471. JAMA Psychiatry. 2021. PMID: 34287621 Free PMC article.

2

Cannabis use and risk of psychosis in later life.

Nordentoft M, Hjorthøj C. Nordentoft M, et al. Among authors: hjorthoj c. Lancet. 2007 Jul 28;370(9584):293-4. doi: 10.1016/S0140-6736(07)61135-0. Lancet. 2007. PMID: 17662860 No abstract available.

3

Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.

Hjorthøj C, Fohlmann A, Larsen AM, Madsen MT, Vesterager L, Gluud C, Arendt MC, Nordentoft M. Hjorthøj C, et al. Trials. 2008 Jul 11;9:42. doi: 10.1186/1745-6215-9-42. Trials. 2008. PMID: 18620563 Free PMC article.

4

[Cannabis and cannabinoid receptors--abuse and psychosis].

Hjorthøj C, Nordentoft M, Fink-Jensen A. Hjorthøj C, et al. Ugeskr Laeger. 2008 Nov 10;170(46):3782-4. Ugeskr Laeger. 2008. PMID: 19014732 Danish.

5

Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.

Hjorthøj C, Fohlmann A, Nordentoft M. Hjorthøj C, et al. Addict Behav. 2009 Jun-Jul;34(6-7):520-5. doi: 10.1016/j.addbeh.2009.02.001. Epub 2009 Feb 25. Addict Behav. 2009. PMID: 19268481 Review.

6

Reprint of "Treatment of cannabis use disorders in people with schizophrenia spectrum disorders--a systematic review".

Hjorthøj C, Fohlmann A, Nordentoft M. Hjorthøj C, et al. Addict Behav. 2009 Oct;34(10):846-51. doi: 10.1016/j.addbeh.2009.02.003. Epub 2009 Jul 15. Addict Behav. 2009. PMID: 19604646

7

Psychiatric disorders and mortality among people in homeless shelters in Denmark: a nationwide register-based cohort study.

Nielsen SF, Hjorthøj CR, Erlangsen A, Nordentoft M. Nielsen SF, et al. Lancet. 2011 Jun 25;377(9784):2205-14. doi: 10.1016/S0140-6736(11)60747-2. Epub 2011 Jun 14. Lancet. 2011. PMID: 21676456

8

Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances--systematic review and meta-analysis.

Hjorthøj CR, Hjorthøj AR, Nordentoft M. Hjorthøj CR, et al. Addict Behav. 2012 Mar;37(3):225-33. doi: 10.1016/j.addbeh.2011.11.025. Epub 2011 Nov 26. Addict Behav. 2012. PMID: 22143002 Review.

9

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.

Hjorthøj CR, Fohlmann A, Larsen AM, Arendt M, Nordentoft M. Hjorthøj CR, et al. Addiction. 2012 Jun;107(6):1123-31. doi: 10.1111/j.1360-0443.2011.03757.x. Epub 2012 Feb 13. Addiction. 2012. PMID: 22151583 Clinical Trial.

10

Does the EQ-5D measure quality of life in schizophrenia?

Halling Hastrup L, Nordentoft M, Hjorthøj C, Gyrd-Hansen D. Halling Hastrup L, et al. Among authors: hjorthoj c. J Ment Health Policy Econ. 2011 Dec;14(4):187-96. J Ment Health Policy Econ. 2011. PMID: 22345360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page